ArticleScientific reports2025

Targeting LAG3 to alter the tumor immune reactivity of CD8+T cells is a potential therapy for skin cutaneous melanoma.

Jin Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.